바이오로직스 자료
Implementing Global Supply Risk Mitigation Through Multi-sourcing
Since the advent of COVID-19, all industries have faced increased business risk associated with unpredictable supply chains. Responsible for developing and manufacturing COVID-19 vaccines and treatments, the pharmaceutical industry in particular has had to rapidly overcome supply chain challenges concurrent with heightened demand. David King, our Director of Drug Product Operations discusses how CDMO partners and drug developers have embraced multi-sourcing strategy to ensure uninterrupted manufacturing and mitigate supply risks.
Since the advent of COVID-19, all industries have faced increased business risk associated with unpredictable supply chains. Responsible for developing and manufacturing COVID-19 vaccines and treatments, the pharmaceutical industry in particular has had to rapidly overcome supply chain challenges concurrent with heightened demand. David King, our Director of Drug Product Operations discusses how CDMO partners and drug developers have embraced multi-sourcing strategy to ensure uninterrupted manufacturing and mitigate supply risks.